IL115810A0 - Method for treating anxiety - Google Patents
Method for treating anxietyInfo
- Publication number
- IL115810A0 IL115810A0 IL11581095A IL11581095A IL115810A0 IL 115810 A0 IL115810 A0 IL 115810A0 IL 11581095 A IL11581095 A IL 11581095A IL 11581095 A IL11581095 A IL 11581095A IL 115810 A0 IL115810 A0 IL 115810A0
- Authority
- IL
- Israel
- Prior art keywords
- branched
- straight
- alkyl
- phenyl
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/332,186 US5488056A (en) | 1994-10-31 | 1994-10-31 | Method for treating anxiety |
US08/336,589 US5484794A (en) | 1994-11-09 | 1994-11-09 | Method for treating anxiety |
Publications (1)
Publication Number | Publication Date |
---|---|
IL115810A0 true IL115810A0 (en) | 1996-01-19 |
Family
ID=26988105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11581095A IL115810A0 (en) | 1994-10-31 | 1995-10-30 | Method for treating anxiety |
Country Status (13)
Country | Link |
---|---|
US (1) | US5726193A (el) |
EP (1) | EP0709093B1 (el) |
JP (1) | JPH10508027A (el) |
AT (1) | ATE191343T1 (el) |
AU (1) | AU4017295A (el) |
CA (1) | CA2202781A1 (el) |
DE (1) | DE69516075T2 (el) |
DK (1) | DK0709093T3 (el) |
ES (1) | ES2144582T3 (el) |
GR (1) | GR3033783T3 (el) |
IL (1) | IL115810A0 (el) |
PT (1) | PT709093E (el) |
WO (1) | WO1996013166A1 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852037A (en) * | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
US5763457A (en) * | 1995-11-13 | 1998-06-09 | Eli Lilly And Company | Method for treating anxiety |
US5998434A (en) * | 1995-12-06 | 1999-12-07 | Eli Lilly And Company | Composition for treating pain |
US6391922B1 (en) | 1998-01-13 | 2002-05-21 | Synchroneuron, Llc | Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders |
EP2291181B9 (en) | 2008-04-18 | 2013-09-11 | University College Dublin National University Of Ireland, Dublin | Captodiamine for the treatment of depression symptoms |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL83275A (en) * | 1986-09-08 | 1994-02-27 | Novo Nordisk As | Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them |
NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
DK198390D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
DK198490D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5330994A (en) * | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
ES2160127T3 (es) * | 1993-08-19 | 2001-11-01 | Novo Nordisk As | Metodo antipsicotico con derivados de tiadiazol y oxadiazol. |
CZ285030B6 (cs) * | 1993-08-19 | 1999-05-12 | Novo Nordisk A/S | Použití thiadiazolových a oxadiazolových sloučenin pro výrobu farmaceutického prostředku a farmacetický prostředek pro léčení schizofrenie nebo schizofrenních nemocí |
-
1995
- 1995-05-24 US US08/449,165 patent/US5726193A/en not_active Expired - Fee Related
- 1995-10-30 IL IL11581095A patent/IL115810A0/xx unknown
- 1995-10-30 AT AT95307741T patent/ATE191343T1/de not_active IP Right Cessation
- 1995-10-30 EP EP95307741A patent/EP0709093B1/en not_active Expired - Lifetime
- 1995-10-30 PT PT95307741T patent/PT709093E/pt unknown
- 1995-10-30 DE DE69516075T patent/DE69516075T2/de not_active Expired - Fee Related
- 1995-10-30 ES ES95307741T patent/ES2144582T3/es not_active Expired - Lifetime
- 1995-10-30 DK DK95307741T patent/DK0709093T3/da active
- 1995-10-30 CA CA002202781A patent/CA2202781A1/en not_active Abandoned
- 1995-10-30 WO PCT/US1995/014049 patent/WO1996013166A1/en active Search and Examination
- 1995-10-30 AU AU40172/95A patent/AU4017295A/en not_active Abandoned
- 1995-10-30 JP JP8514809A patent/JPH10508027A/ja not_active Withdrawn
-
2000
- 2000-06-27 GR GR20000401482T patent/GR3033783T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH10508027A (ja) | 1998-08-04 |
CA2202781A1 (en) | 1996-05-09 |
EP0709093B1 (en) | 2000-04-05 |
ES2144582T3 (es) | 2000-06-16 |
GR3033783T3 (en) | 2000-10-31 |
US5726193A (en) | 1998-03-10 |
PT709093E (pt) | 2000-08-31 |
EP0709093A2 (en) | 1996-05-01 |
DE69516075D1 (de) | 2000-05-11 |
WO1996013166A1 (en) | 1996-05-09 |
EP0709093A3 (el) | 1996-05-29 |
ATE191343T1 (de) | 2000-04-15 |
DE69516075T2 (de) | 2000-09-14 |
DK0709093T3 (da) | 2000-07-10 |
AU4017295A (en) | 1996-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8401486A1 (es) | Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina. | |
PE46899A1 (es) | Derivados de n-fenil-sulfonamida | |
NZ325569A (en) | 2-substituted phenyl-1H-indole derivatives which are antagonists of gonadotropin releasing hormone | |
NO169286C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolin-2-okso-1-karboksylsyrederivater | |
DE69516076D1 (de) | Tetrahydropyridin Oxadiazol- oder -Thiadiazol-Verbindung zur Behandlung von Angstzuständen | |
HUP0204246A2 (hu) | Új tiazolo[4,5-d]pirimidin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
EP1411052A4 (en) | BENZO-CONDENSED 5-CHAIN HETEROCYCLE COMPOUNDS, PROCESS FOR PREPARING SAME AND USE THEREOF | |
IL115810A0 (en) | Method for treating anxiety | |
SG48068A1 (en) | 7-(2-Aminoethyl)-benzothiazolones | |
CA2169838A1 (en) | Antipsychotic method | |
DE69131759D1 (de) | An den Positionen 2 und 9 substituierte 4H-pyrido-(1,2-a)pyrimidin-4-one | |
PT85008A (en) | Process for the preparation of 2-thiazolil-imidazo ]1,2-c" pyrimidines of their salts of acid addition and of pharmaceutical composicoes containing them | |
GR80839B (en) | Ii-substituted 5h,iih-pyrrolo (2,1-c) (1,4) benzoxazepine a process for their preparation and their use as medicaments | |
NO975094L (no) | Vinylpyrrolidoncefalosporinderivater | |
AU1060592A (en) | N-(aryloxyalkyl)heteroaryl-8-azabicyclo(3,2,1)octanes, intermediates and a process for the preparation thereof and their use as medicaments | |
MY125562A (en) | Hexahydro-pyrido (4,3-b) indole derivatives as antipsychotic drugs | |
CA2155493A1 (en) | Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives | |
GB9209330D0 (en) | Chemical compounds | |
NO861868L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatian-derivater. | |
MY103825A (en) | Novel basic-substituted 5-halo-thienoisothiazol-3(2h)- one 1, 1-dioxides, a process for the preparation thereof, and pharmaceutical preparation containing these compounds | |
ES8802507A1 (es) | Procedimiento para preparar eteres 1,3-dioxano. | |
ATE208761T1 (de) | Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
MX9701252A (es) | Derivados de diarilalcano que contienen un grupo aliciclico, su preparacion y sus usos terapeutico y profilactico. | |
ES2005778A6 (es) | Procedimiento para la obtencion de derivados de diisobutilxantina. |